Skip to main content
. 2019 Jun 11;10:171–186. doi: 10.2147/PROM.S178344

Figure 2.

Figure 2

US Food and Drug Administration (FDA) guidance for industry on PRO evaluation.

Note: Data from FDA.12

Abbreviation: PRO, patient-reported outcome.